Search results
Merck stops skin cancer combination therapy testing in late-stage study
WSAU Wausau· 29 minutes ago(Reuters) -Merck has discontinued testing a combination of an experimental antibody-based drug and...
Merck Study of Keytruda With Chemotherapy in Endometrial Cancer Fails to Meet Endpoint
Morningstar· 4 days agoMerck was hit with a setback in its efforts to expand its blockbuster cancer immunotherapy Keytruda after a late-stage study of its use in combination with ...
Medicenna Provides Update on its Presentations at the 2024 ASCO Annual Meeting
Digital Journal· 1 hour agoASCO has informed the Company that the previously accepted MDNA11 oral abstract has been withdrawn due to alleged violation of their prior publication policy based solely on their review of ...
How mRNA vaccines could be personalized cancer cures
Axios· 6 days agoAn expanding pipeline of vaccines is giving patients new hope against some of the deadliest cancers, by training the body's immune system to attack...
Calliditas' survival data salvage midphase cancer trial after primary endpoint miss
FierceBiotech· 6 days agoCalliditas Therapeutics had a typical to-do list for its midphase head and neck cancer study. Step...
The doctor behind the next big thing in cancer treatment
CNN via Yahoo News· 4 days agoDr Catherine Wu’s research has laid the scientific foundation for the development of cancer vaccines...
Bavencio Side Effects: What They Are and How to Manage Them
Healthline· 6 days agoBavencio (avelumab) is a prescription drug used to treat certain types of kidney, bladder, and skin cancer. Bavencio can cause side effects that range from mild to serious. Examples include ...
What is the Outlook for a Mesothelioma Diagnosis?
Daily Sundial· 6 days agoOver the past 15 or 20 years, a rare form of cancer known as mesothelioma has become increasingly common – affecting as many as 3,000 Americans each year. What is Mesothelioma? Mesothelioma ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 7 days agoJennifer Grey to be Honored for Her Cancer Advocacy, Along with Chief Strategy & Marketing Officer for GE Healthcare Andy DeLaO and Renowned Cancer Physician-Scientist Dr. Antoni Ribas at Tower Cancer Research Foundation's 22nd Annual Tower of Hope
